• Department of Neurology; West China Hospital; Sichuan University; Chinese Evidence-Based Medicine/Cochrane Center; Chengdu; 610041 China;
Export PDF Favorites Scan Get Citation

Objective  To assess the effectiveness and safety of one kind of ACEI—Ramipril, for providing proofs for clinical implement and we also tried to explore the practical method of evidence-based drug assessment.
Method  By using the methods and principles of systematic review (SR), and health technology assessment (HTA), we searched Medline and Cochrane Library, together with related materials provided by pharmaceutics and collected all the published clinical research reports on Ramipril. Based on principles of SR and HTA, we assessed all the included reports comprehensively.
Results  We totally collected 214 articles about Ramipril, in which there were 18 articles meeting the inclusion criteria and 31 139 patients were enrolled in these studies. The research contents include: hypertension, diabetes mellitus, heart failure, myocardial infarction, nephropathy and secondary prevention for cardio-cerebral vascular disease.
Conclusion  According to our clinical evidence assessment, Ramipril is an effective, safe and easy to take drug and is worthy to spread.

Citation: YUAN Qiang,LIU Ming,LAI Xiaohiu. Comprehensive assessment of clinical evidence for Ramipril——an exploration of evidence-based drug assessment. Chinese Journal of Evidence-Based Medicine, 2001, 01(1): 25-29. doi: Copy